Peptomyc
Barcelona, ES · 3 known investors
Peptomyc is a biotech company developing MYC inhibitors for cancer treatment, based on the Omomyc molecule, and is advancing them through preclinical and clinical trials. It operates in oncology drug development, with its research group linked to the Vall d'Hebron Institute of Oncology in Barcelona, Spain.
Founders & leadership
DL
Dr. Laura SoucekCo-founder and CEO
DM
Dr. Marie-Eve BeaulieuCo-founder
LS
Laura SoucekCo-founder & CSO (former CEO)
Investors · 3
Frequently asked questions
- What does Peptomyc do?
- Peptomyc is a biotech company developing MYC inhibitors for cancer treatment, based on the Omomyc molecule, and is advancing them through preclinical and clinical trials. It operates in oncology drug development, with its research group linked to the Vall d'Hebron Institute of Oncology in Barcelona, Spain.
- Who founded Peptomyc?
- Peptomyc was founded by Dr. Laura Soucek, Dr. Marie-Eve Beaulieu, Laura Soucek.
- Who are Peptomyc's investors?
- Peptomyc's investors include Aurora Science, Invivo Capital Partners, Asabys Partners.
- Where is Peptomyc headquartered?
- Peptomyc is headquartered in Barcelona, ES.